Advertisement

Molekulare Mechanismen der neonatalen Abwehr von bakteriellen Infektionen

  • Reinhard Berner
Part of the Molekulare Medizin book series (MOLMED)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

5.2.7 Literatur

  1. Anderson DC, Hughes BJ, Smith CW (1981) Abnormal mobility of neonatal polymorphonuclear leukocytes. J Clin Invest 68:863–874PubMedCrossRefGoogle Scholar
  2. Anderson DC, Rothlein R, Marlin SD et al (1990) Impaired transendothelial migration by neonatal neutrophils: abnormalities of Mac-1 (CDllb/CD18)-dependent adherence reactions. Blood 76:2613–2621PubMedGoogle Scholar
  3. Anderson DC, Abbassi O, Kishimoto TK et al (1991) Diminished lection, epidermal growth factor, complement binding domain-cell adhesion molecule-1 on neonatal neutrophils underlies their impaired CD18-independent adhesion to endothelial cells in vitro. J Immunol 146:3372–3379PubMedGoogle Scholar
  4. Bailie KE, Irvine AE, Bridges JM, McClure BG (1994) Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery. Pediatr Res 35:164–168PubMedCrossRefGoogle Scholar
  5. Baker CJ, Kasper DL (1976) Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med 294:753–756PubMedCrossRefGoogle Scholar
  6. Baley JE, Stork EK, Warkentin PI, Shurin SB (1988) Neonatal neutropenia. Clinical manifestations, cause, and outcome. Am J Dis Child 142:1161–1166PubMedGoogle Scholar
  7. Baltimore RS, Huie SM, Meek JI et al (2001) Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 108:1094–1098CrossRefPubMedGoogle Scholar
  8. Barak Y, Leibovitz E, Mogilner B et al (1997) The in vivo effect of recombinant human granulocyte colony-stimulating factor in neutropenic neonates with sepsis. Eur J Pediatr 156:643–646CrossRefPubMedGoogle Scholar
  9. Bauer K, Zemlin M, Hummel M et al (2002) Diversification of Ig heavy chain genes in human preterm neonates prematurely exposed to environmental antigens. J Immunol 169:1349–1356PubMedGoogle Scholar
  10. Berner R (2002) Group B streptococci in pregnancy and infancy. Curr Opin Infect Dis 15:307–313PubMedGoogle Scholar
  11. Berner R, Niemeyer CM, Leititis JU et al (1998) Plasma levels and gene-expression of G-CSF, TNF-α, IL-1β, IL-6, IL-8, and sICAM-1 in neonatal early-onset sepsis. Pediatr Res 44:469–477PubMedCrossRefGoogle Scholar
  12. Berner R, Tüxen B, Clad A, Forster J, Brandis M (2000) Elevated gene-expression of interleukin-8 in cord blood is a sensitive marker of neonatal infection. Eur J Pediatr 159:205–210PubMedCrossRefGoogle Scholar
  13. Berner R, Csorba J, Brandis M (2001) Different cytokine expression in cordblood mononuclear cells (CBMNC) after Stimulation with neonatal sepsis or colonizing strains of Streptococcus agalactiae. Pediatr Res 49:691–697PubMedCrossRefGoogle Scholar
  14. Berner R, Welter P, Brandis M (2002a) Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr Res 51:304–309PubMedCrossRefGoogle Scholar
  15. Berner R, Fuerll B, Stelter F, Droese J, Mueller HP, Schuett C (2002 b) Elevated plasma levels of lipopolysaccharide binding protein (LBP) and soluble CD14 in neonatal early onset sepsis. Clin Diagn Lab Immunol 9:440–445CrossRefPubMedGoogle Scholar
  16. Billiau A (1998) Gamma-interferon: the match that lights the fire? Immunology Today 9:37–40CrossRefGoogle Scholar
  17. Bohnsack JF, Takahashi S, Hammitt L, Miller DV, Aly AA, Adderson EE (2000) Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a. Infect Immun 68:5018–5025CrossRefPubMedGoogle Scholar
  18. Bouchon A, Facchetti F, Weigand MA, Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103–1107CrossRefPubMedGoogle Scholar
  19. Bührer C, Graulich J, Stibenz D, Dudenhausen JW, Obladen M (1994) L-Selectin is down-regulated in umbilical cord blood granulocytes and monocytes of newborn infants with acute bacterial infection. Pediatr Res 36:799–804PubMedCrossRefGoogle Scholar
  20. Cairo MS (1989) Neonatal neutrophil host defense. Am J Dis Child 143:40–56PubMedGoogle Scholar
  21. Cairo MS (1991) Cytokines: a new immunotherapy. Clin Perinatol 18:343–359PubMedGoogle Scholar
  22. Cairo MS, Plunkett J, Mauss D, van de Ven C (1990) Seven-day administration of recombinant granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B streptococcal sepsis. Blood 76:1788–1794PubMedGoogle Scholar
  23. Carr R, Modi N, Doré CJ, El-Rifai R, Lindo D (1999) A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics 103:796–802CrossRefPubMedGoogle Scholar
  24. Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545–568CrossRefPubMedGoogle Scholar
  25. Cederqvist LL, Ewool LC, Litwin SD (1978) The effect of fetal age, birth weight, and sex on cord blood immunoglobulin values. Am J Obstet Gynecol 131:520–525PubMedGoogle Scholar
  26. Chalmers IM, Janossy G, Contreras M, Navarrete C (1998) Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 92:11–18PubMedGoogle Scholar
  27. Cheng Q, Carlson B, Pillai S et al (2001) Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. Infect Immun 69:2302–2308PubMedCrossRefGoogle Scholar
  28. Christensen RD, Rothstein G (1980) Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 96:316–318PubMedCrossRefGoogle Scholar
  29. Christensen RD, Rothstein G (1984) Pre and postnatal development of granulocyte stem cells (CFUc) in the rat. Pediatr Res 18:599–602PubMedCrossRefGoogle Scholar
  30. Christensen RD, MacFarlane JL, Taylor NL et al (1982) Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferative, storage and circulating pools. Pediatr Res 16:549–553PubMedGoogle Scholar
  31. Christensen RD, Harper TE, Rothstein G (1986) Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr 109:1047–1051PubMedCrossRefGoogle Scholar
  32. Cuzzola M, Mancuso G, Beninati C et al (2000a) Human monocyte receptors involved in tumor necrosis factor responses to group B streptococcal products. Infect Immun 68:994–998CrossRefPubMedGoogle Scholar
  33. Cuzzola M, Mancuso G, Beninati C et al (2000b) β2 integrins are involved in cytokine responses to whole grampositive bacteria. J Immunol 164:5871–5876PubMedGoogle Scholar
  34. Davies HD, Adair C, McGeer A et al (2001) Antibodies to capsular polysaccharides of group B streptococcus in pregnant Canadian women: relationship to colonization Status and infection in the neonate. J Infect Dis 184:285–291CrossRefPubMedGoogle Scholar
  35. Davies NP, Buggins AG, Snijders RJ, Jenkins E, Layton DM, Nicolaides KH (1992) Blood leucocyte count in the human fetus. Arch Dis Child 399–403Google Scholar
  36. Dinauer MC (1998) The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Nathan DG, Orkin SH (eds) Hematology of infancy and childhood, 5th edn. Saunders, Philadelphia, pp 889–967Google Scholar
  37. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA (1994) The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci USA 91:1863–1867PubMedCrossRefGoogle Scholar
  38. Feikin DR, Thorsan P, Zywicki S et al (2001) Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women. Am J Obstet Gynecol 184:427–433CrossRefPubMedGoogle Scholar
  39. Flo TH, Haiaas O, Lien E et al (2000) Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 164:2046–2049Google Scholar
  40. Forsthuber T, Yip HC, Lehmann PV (1996) Induction of Th1 and Th2 immunity in neonatal mice. Science 271:1728–1730PubMedCrossRefGoogle Scholar
  41. Funke A, Berner R, Traichel B, Schmeisser D, Leititis JU, Niemeyer CM (2000) Frequency, natural course and outcome of neonatal neutropenia. Pediatrics 106:45–51CrossRefPubMedGoogle Scholar
  42. Furth van R, Raeburn JA, Van Zwet TL (1979) Characteristics of human mononuclear phagocytes. Blood 54:485–500PubMedGoogle Scholar
  43. Ganz T, Lehrer RI (1999) Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today 5:292–297PubMedCrossRefGoogle Scholar
  44. Gessler P, Kirchmann N, Kientsch-Engel R, Haas N, Lasch P, Kachel W (1993) Serum concentrations of granulocyte colony-stimulating factor in healthy term and preterm neonates and in those with various diseases including bacterial infections. Blood 82:3177–3182PubMedGoogle Scholar
  45. Gillian ER, Christensen RD, Suen Y, Ellis R, van de Ven C, Cairo SC (1994) A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia. Blood 84:1427–1433Google Scholar
  46. Girschick HJ, Lipsky PE (2002) The kappa gene repertoire of human neonatal B cells. Mol Immunol 38:1113–1127CrossRefPubMedGoogle Scholar
  47. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS (1990) A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 9:819–825PubMedCrossRefGoogle Scholar
  48. Glaser P, Rusniok C, Buchrieser C et al (2002) Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 45:1499–1513CrossRefPubMedGoogle Scholar
  49. Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I (1995) Premature labor and intra-amniotic infection: clinical aspects and the role of cytokines in diagnosis an pathophysiology. Clin Perinatol 22:281–342PubMedGoogle Scholar
  50. Griffioen AW, Toebes EA, Zegers BJ, Rijkers GT (1992) Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide. Cell Immunol 143:11–22CrossRefPubMedGoogle Scholar
  51. Heine RP, Wiesenfeld H, Mortimer L, Greig PC (1998) Amniotic fluid defensins: potential marker of subclinical intrauterine infection. Clin Infect Dis 27:513–518PubMedCrossRefGoogle Scholar
  52. Henneke P, Takeuchi O, van Strijp JA et al (2001) Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci. J Immunol 167:7069–7076PubMedGoogle Scholar
  53. Henneke P, Takeuchi O, Malley R et al (2002) Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol 169:3970–3977PubMedGoogle Scholar
  54. Jones HD, Schmalstieg FC, Dempsey K et al (1990) Subcellular distribution and mobilization of Mac-1 (CD llb/CD18) in neonatal neutrophils. Blood 75:488–498PubMedGoogle Scholar
  55. Karlsson H, Hessle C, Rudin A (2002) Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 70:6688–6696PubMedCrossRefGoogle Scholar
  56. Kasper DL, Paoletti LC, Wessels MR et al (1996) Immune response to type III group B streptococcal polysaccharidetetanus toxoid conjugate vaccine. J Clin Invest 98:2308–2314PubMedCrossRefGoogle Scholar
  57. Kohler PF (1973) Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis. J Clin Invest 52:671–673PubMedCrossRefGoogle Scholar
  58. Kwak DJ, Augustine NH, Borges WG, Joyner JL, Green WF, Hill HR (2000) Intracellular and extracellular cytokine production by human mixed mononuclear cells in response to group B streptococci. Infect Immun 68:320–327PubMedCrossRefGoogle Scholar
  59. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, Zimmerli W (1996) Human monocyte CD14 is upregulated by lipopolysaccharid. Infect Immun 64:1762–1769PubMedGoogle Scholar
  60. Levy O (2002) Impaired innate immunity at birth: deficiencies of bactericidal/permeability-increasing protein (BPI) in the neutrophils of newborns. Pediatr Res 51:667–669CrossRefPubMedGoogle Scholar
  61. Levy O, Martin S, Eichenwald E et al (1999) Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein (BPI). Pediatrics 104:1327–1333CrossRefPubMedGoogle Scholar
  62. Lewis DB, Wilson CB (1995) Developmental immunology and role of host defenses in neonatal susceptibility to infection. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 4th edn. Saunders, Philadelphia, p 20Google Scholar
  63. Lien E, Ingalls RR (2002) Toll-like receptors. Crit Care Med 30 (Suppl):1–11CrossRefGoogle Scholar
  64. Lin FY, Phillips JB III, Azimi PH et al (2001) Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: a multicenter, seroepidemiology study. J Infect Dis 184: 1022–1028PubMedCrossRefGoogle Scholar
  65. Locatelli F, Rocha V, Chastang C et al (1999) Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 93:3662–3671PubMedGoogle Scholar
  66. Manroe BL, Weinberg AG, Rosenfeld CR, Browne R (1979) The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 95:89–98PubMedCrossRefGoogle Scholar
  67. Marshall-Clarke S, Reen D, Tasker L, Hassan J (2000) Neonatal immunity: how well has it grown up? Immunol Today 21Google Scholar
  68. Medvedev AE, Flo T, Ingalls RR, Golenbock DT, Teti G, Vogel SN, Espevik T (1998) Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-B activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J Immunol 160:4535–4542PubMedGoogle Scholar
  69. Medzhitov R, Janeway C (2000) Innate immunity. N Engl J Med 343:338–344CrossRefPubMedGoogle Scholar
  70. Mehr S, Doyle KW (2000) Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J 19:879–887PubMedCrossRefGoogle Scholar
  71. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R (1994) Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 94:76–82PubMedGoogle Scholar
  72. Nupponen I, Turunen R, Nevalainen T, Peuravuori H, Pohjavuori M, Repo H, Andersson S (2002) Extracellular release of bactericidal/permeability-increasing protein in newborn infants. Pediatr Res 51:670–674CrossRefPubMedGoogle Scholar
  73. Opal SM, Scannon PJ, Vincent JL et al (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584–1589CrossRefPubMedGoogle Scholar
  74. Paoletti LC, Rench MA, Kasper DL et al (2001) Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccine. Infect Immun 69:6696–6701CrossRefPubMedGoogle Scholar
  75. Pedraz C, Lorente F, Pedraz MJ, Salazar Villalobos V (1980) Development of the serum levels of complement during the first year of life. An Esp Pediatr 13:571–576PubMedGoogle Scholar
  76. Qian JX, Lee SM, Suen Y, Knoppel E, van de Ven C, Cairo MS (1997) Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 90:3106–3117PubMedGoogle Scholar
  77. Ridge JP, Fuchs EJ, Matzinger P (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271:1723–1726PubMedCrossRefGoogle Scholar
  78. Ridge JP, Di Rosa F, Matzinger P (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393:474–478CrossRefPubMedGoogle Scholar
  79. Sáez-Llorens X, McCracken GH Jr (1993) Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr 123:497–508PubMedCrossRefGoogle Scholar
  80. Schaller-Bals S, Schulze A, Bals R (2002) Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am J Respir Crit Care Med 165:992–995PubMedGoogle Scholar
  81. Schibier KR, Liechty KW, White WL, Rothstein G, Christensen RD (1992) Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host deficiencies of neonates. Pediatr Res 31:18–21Google Scholar
  82. Schibier KR, Osborne KA, Leung LY, Le TV, Baker SI, Thompson DD (1998) A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis. Pediatrics 102:6–13CrossRefGoogle Scholar
  83. Schlievert PM, Gocke JE, Deringer JR (1993) Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17:26–31PubMedGoogle Scholar
  84. Schrag SJ, Zywicki S, Farley MM et al (2000) Group B streptococcal disease in the era of intrapartum prophylaxis. N Engl J Med 342:15–20CrossRefPubMedGoogle Scholar
  85. Schuchat A (2001) Group B streptococcal disease: from trials and tribulations to triumph and trepidation. Clin Infect Dis 33:751–756CrossRefPubMedGoogle Scholar
  86. Schuchat A, Zywicki SS, Dinsmoor MJ et al (2002) Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 105:21–26CrossRefGoogle Scholar
  87. Schuit KE, Homisch L (1984) Inefficient in vivo neutrophil migration in neonatal rats. J Leukoc Biol 35:583–586PubMedGoogle Scholar
  88. Schultz C, Rott C, Richter N, Bucsky P, Reiss I, Gortner L (1999) Intracytoplasmic detection of cytokines in neonatal lymphocytes and monocytes by flow cytometry. Blood 93:3566–3567PubMedGoogle Scholar
  89. Schultz C, Rott C, Temming P, Schlenke P, Moller JC, Bucsky P (2002) Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 51:317–322PubMedCrossRefGoogle Scholar
  90. Scott ME, Kubin M, Kohl S (1997) High level interleukin-12 production, but diminished interferon-γ production, by cord blood mononuclear cells. Pediatr Res 41:547–553PubMedCrossRefGoogle Scholar
  91. Shalak LF, Laptook AR, Jafri HS, Ramilo O, Perlman JM (2002) Clinical chorioamnionitis, elevated cytokines, and brain injury in term infants. Pediatrics 110:673–680CrossRefPubMedGoogle Scholar
  92. Singh B, Merchant P, Walker CR, Kryworuchko M, Diaz-Mitoma F (1996) Interleukin-6 expression in cord blood of patients with clinical chorioamnionitis. Pediatr Res 39:976–979PubMedCrossRefGoogle Scholar
  93. Slattery MM, Morrison JJ (2002) Preterm delivery. Lancet 360:1489–1497CrossRefPubMedGoogle Scholar
  94. Smith JB, Campbell DE, Ludomirsky A et al (1990) Expression of the complement receptors CR1 and CR3 ant the type III Fcγ receptor on neutrophils from newborn infants and from fetuses with Rh disease. Pediatr Res 28:120–126PubMedCrossRefGoogle Scholar
  95. Sprenger H, Gemsa D (1999) Angeborene Mechanismen der Infektabwehr. In: Ganten D, Ruckpaul K (Hrsg) Immunsystem und Infektiologie. Handbuch der molekularen Medizin, Bd 4. Springer, Berlin Heidelberg New York Tokio, S 317–340Google Scholar
  96. Stiehm ER, Fudenberg HH (1966) Serum levels of immune globulins in health and disease: a survey. Pediatrics 37:715–717PubMedGoogle Scholar
  97. Thomas CA, Li Y, Kodama T, Suzuki H, Silverstein SC, El Khoury J (2000) Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med 191:147–156CrossRefPubMedGoogle Scholar
  98. Tsuji H, Mukaida N, Harada A et al (1999) Allevation of lipopolysaccharide-induced acute liver injury in Propioni-bacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production. J Immunol 162:1049–1055PubMedGoogle Scholar
  99. Vallejo JG, Knuefermann P, Mann DL, Sivasbramanian (2000) Group B streptococcus induces TNF-α gene expression and activation of the transcription factors NF-κB and activator protein-1 in human cord blood monocytes. J Immunol 165:419–425PubMedGoogle Scholar
  100. Vasselon T, Detmers PA (2002) Toll-receptors: a central element in innate immune responses. Infect Immun 70:1033–1041CrossRefPubMedGoogle Scholar
  101. Vreugdenhil AC, Dentener MA, Snoek AM, Greve JW, Buurman WA (1999) Lipopolysaccharide binding protein and serum amyloid a secretion by human intestinal epithelial cells during the acute phase response. J Immunol 163:2792–2798PubMedGoogle Scholar
  102. Washington State Vital Statistics 2000 (2002) Center for Health Statistics, Olympia, WashingtonGoogle Scholar
  103. Weatherstone K, Rieh E (1989) Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res 25:342–346PubMedCrossRefGoogle Scholar
  104. Wheeler AP, Bernard GR (1999) Treating patients with severe sepsis. N Engl J Med 3:207–214CrossRefGoogle Scholar
  105. Williams PA, Bohnsack JF, Augustine NH, Drummond WK, Rubens CE, Hill HR (1993) Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr 123:292–300PubMedCrossRefGoogle Scholar
  106. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharides (LPS) and LPS binding protein. Science 249:1431–1433PubMedCrossRefGoogle Scholar
  107. Yachie A, Takano N, Ohta K, Uehara T, Fujita S, Miyawaki T, Taniguchi N (1992) Defective production of IL-6 in very small premature infants in response to bacterial pathogens. Infect Immun 60:749–753PubMedGoogle Scholar
  108. Zemlin M, Bauer K, Hummel M et al (2001) The diversity of rearranged immunoglobulin heavy chain variable region genes in peripheral blood B cells of preterm infants is restricted by short third complementarity-determining regions but not by limited gene segment usage. Blood 97:1511–1513CrossRefPubMedGoogle Scholar
  109. Zilow EP, Brüssau J, Linderkamp O, Zilow G (1995) In vitro activation of classical and alternative pathway of the complement system. Pediatr Res 38:462Google Scholar
  110. Zilow G, Zilow EP, Burger R, Linderkamp O (1993) Complement activation in newborn infants with early onset infection. Pediatr Res 34:199–203PubMedCrossRefGoogle Scholar
  111. Zilow G, Brüssau J, Hauck W, Zilow EP (1994) Complement factor 9 deficiency in term and preterm neonates. Immunobiology 191:306Google Scholar
  112. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR (2001) High concentrations of lipopolysaccharid-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response of human monocytes. Blood 98:3800–3808CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Reinhard Berner
    • 1
  1. 1.Zentrum für Kinderheilkunde und JugendmedizinUniversität FreiburgFreiburg

Personalised recommendations